CUE BIOPHARMA INC

Historical 13F Holders

Symbol
CUE
CUSIP
22978P205
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 22978P205 since 12/18/2024, largest first.

Filer % of Class Filed
Driehaus Capital Management LLC 13G 7.0% 8/14/2026
Event 6/30/2026
Shao-Lee Lin 13D 6.2% 8/21/2026
Event 5/3/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Mark E. Strome 13G/A
8.5%
Checked 5% or less
10/8/2026
Event 7/14/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 53 1.66 M $52.2 M
2026 Q1 2 1.70 k $391.00